[ad_1] Glenmark Pharmaceuticals’ wholly owned subsidiary Ichnos Sciences, a clinical-stage oncology biotech, and Astria Therapeutics, a biopharmaceutical company developing therapies for allergic and immunological diseases, on Thursday […]